Esser-Kahn Group

Tyler Albin

Tyler grew up in Washington State (go Hawks!), where he discovered his passion for chemistry in high school. He began his research career at Western Washington University in Bellingham, Washington. There, he spent several years encouraging conducting polymer/silk-peptide conjugates to self-assemble under the mentorship of Professor Amanda Murphy. Tyler has emerged from the Washington clouds to study chemical biology and immune programming at the University of California, Irvine. So far, Tyler has learned to love the sunny winters, amazing hikes, and avocados of California.

Bachelor's
Western Washington University, Bellingham, Washington, 2014
Professor Amanda Murphy

Scientific Hero
Linus Pauling

Quote
"Follow your passion—you'll be surprised you can change the world. So my advice is: pursue that—leave the world better than you found it . . . " —Bill Nye

Chemical biology, immune programming, and biomaterials.

Toll-like Receptor Agonist Conjugation: A Chemical Perspective

Bob J. Ignacio, Tyler J. Albin, Aaron P. Esser-Kahn, and Martijn Verdoes. Toll-like Receptor Agonist Conjugation: A Chemical Perspective. Bioconjugate Chemistry. 2018.

Development of a tri-agonist compound library used to determine optimal adjuvanticity of a Q fever

Janine Tom, Tyler Albin, Amanda Burkhardt, Philip Felgner and Aaron Esser-Kahn. Development of a tri-agonist compound library used to determine optimal adjuvanticity of a Q fever. The Journal of Immunology. 2016. Vol. 196.

Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development

Janine K. Tom, Tyler J. Albin, Saikat Manna, Brittany A. Moser, Rachel C. Steinhardt, Aaron P. Esser-Kahn. Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development. Trends in Biotechnology.